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Abstract
Introduction: Vena cava compression is a relatively rare initial manifestation of underlying malignancy. The superior
vena cava syndrome, which is characterized by facial plethora, jugular venous distension, and arm swelling, is a
well-known entity associated with bronchogenic carcinoma. Less common is the compression of the inferior vena
cava. To the best of my knowledge, this is the first reported case of newly diagnosed gastric adenocarcinoma
presenting initially as the inferior vena cava syndrome. The unique aspect about this case is that it highlights a
rare presentation before diagnosis of gastric adenocarcinoma.
Case presentation: A 56-year-old Malaysian woman with a past medical history of iron deficiency anemia presented
with lower extremity edema and progressive fatigue of 1 month’s duration. She had significant worsening of leg
swelling after standing for short periods of time. She also reported epigastric discomfort, which led to an
additional workup, including computed tomography of the abdomen and pelvis. This revealed a 3cm×2.9cm mass in the
stomach, extensive hepatic metastasis, and severe inferior vena cava compression. The patient was examined further with
esophagogastroduodenoscopy, and a biopsy showed gastric adenocarcinoma.
Conclusions: This report describes a case of a patient with inferior vena cava syndrome as a unique presentation of
previously undiagnosed stage IV gastric adenocarcinoma. Patients presenting with inferior vena cava syndrome should
undergo prompt evaluation for underlying malignancies that have a predilection for hepatic metastasis. This case is
important because earlier recognition of this syndrome can lead to earlier workup and thus detection of malignancy.
Prompt initiation of treatment, including chemotherapy or vena cava stent placement, can result in improved
patient outcome.
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Introduction
The clinical manifestations of malignancy vary tremen-
dously and can include direct mass effect of tumor and
paraneoplastic effects. A paraneoplastic syndrome is fre-
quently the first manifestation of malignancy. Common
paraneoplastic manifestations of gastric adenocarcinoma
include acanthosis nigricans and Leser-Trélat sign [1, 2].
Other features that are mostly unique to gastric cancer
include Virchow’s node, Krukenberg tumor, and Sister
Mary Joseph nodule, though these are not common at
the time of initial presentation [3, 4]. Direct mass effect
is typically detected during clinical examination only
after there is significant imposition upon other anatomic
structures, such as nerves or vessels. For example, symp-
toms such as facial plethora and arm swelling as a result
of the superior vena cava (SVC) syndrome in a patient
with a history of smoking sometimes leads to the workup
and eventual diagnosis of lung cancer. An underlying
cancer is the cause of more than 90% of cases of the SVC
syndrome. Other cancers associated with SVC syndrome
include thymoma, mesothelioma, lymphoma, and germ
cell tumors [5]. However, the clinical presentation of these
malignancies does not include vena cava compression in
most cases.
Correspondence: shyam2@stanford.edu
Department of Medicine, Stanford Hospital and Clinics, Stanford University
School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA
JOURNAL OF MEDICAL
CASE REPORTS
© 2015 Patel. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Patel Journal of Medical Case Reports  (2015) 9:204 
DOI 10.1186/s13256-015-0696-3
There are very few reports of inferior vena cava (IVC)
compression, in contrast to the SVC syndrome, as a
manifestation of underlying malignancy. Some tumors
have been reported to have compressive effects on the
IVC. A recent case report showed that IVC compression
was caused by a mesenteric desmoid tumor in a patient
who presented with acute pulmonary embolism [6].
Neuroblastoma in a neonate who had lower extremity
edema was shown to cause IVC compression [7]. Two
cases of paragangliomas have been reported to cause
IVC compression posteriorly [8].
Case presentation
A 56-year-old Malaysian woman with a past medical
history of anemia presented with lower extremity swell-
ing, early satiety, and abdominal discomfort of 1 month’s
duration. She reported worsening of leg edema upon
standing for short periods of time. She denied chest pain
or shortness of breath. She had emigrated from Malaysia
approximately 10 years before presentation. She had been
taking oral iron supplementation and omeprazole. A col-
onoscopy had been performed 1 year before presentation
to assess for gastrointestinal bleeding, and the results were
normal. Her Helicobacter pylori breath test result was
positive, and she was started on triple therapy with two
antibiotics plus a proton pump inhibitor. An endoscopic
examination was done, and the result was suggestive of a
mass, though the diagnosis was not definitive. Her family
history was not significant. Her social history was signifi-
cant for frequent consumption of fish in Malaysia and was
negative for alcohol, cigarette, or drug use.
Upon her admission to Stanford University Hospital,
she reported a 10-lb weight gain. The weight gain was
caused by edema, though she felt a sensation that she
was becoming thinner. She reported that she was unable
to stand for more than 15 minutes owing to accumula-
tion of fluid in her legs. She reported that her mobility
was thus limited. Her vital signs were stable, with a body
temperature of 37°C, blood pressure of 134/78mmHg,
pulse of 79 beats per minute, and respiratory rate of 18
breaths per minute. Her O2 saturation was 100%. Her
physical examination revealed a grade 3/6 systolic ejec-
tion murmur heard best at the left lower sternal border.
Her abdomen was non-tender to palpation, and her
bowel sounds were normoactive. Examination of the
extremities revealed 2+ non-pitting edema extending to
her thighs bilaterally. She had no palpable peri-umbilical
or supraclavicular nodes. She had no other palpable
lymphadenopathy. Her skin examination was normal.
Laboratory values showed hemoglobin of 8.5g/dl with
mean corpuscular volume of 71.2fl. Her reticulocyte count
was 4.36%. An iron panel revealed ferritin of 32ng/ml,
transferrin of 403μg/dl, transferrin saturation of 3%, and
iron level of 13μg/dl. Her platelet count was 519,000/μl,
and her white blood cell count was normal. Her metabolic
panel was significant for sodium of 134mmol/L. Her liver
function tests were significant for aspartate aminotransfer-
ase of 122U/L, alkaline phosphatase of 478U/L, and albu-
min of 2.3g/dl. Her electrocardiogram showed T-wave
inversions in leads V1–V4 and an S1Q3T3 pattern.
The differential diagnosis included pulmonary embolism
and myocardial injury or ischemia. Her troponin level was
negative. An ultrasound of the lower extremities showed
no deep vein thrombosis. Computed tomography (CT) of
the abdomen and pelvis revealed severe intrahepatic
narrowing of the IVC due to mass effect (Fig. 1) and
an ill-defined 3cm×2.9cm mass involving the antrum
of the stomach (Fig. 2). The CT scans were also notable
for omental implants and nodular extension of the gastric
tumor posteriorly into the lesser sac. She had a small
amount of ascites. The gastric mass was biopsied during
endoscopy (initially at an outside hospital). The histologic
sections of the gastric antrum mass biopsy revealed an
invasive, moderately differentiated adenocarcinoma of in-
testinal type, with formation of glands and nests (Fig. 3).
The biopsy had a pancytokeratin-positive neoplasm. The
patient was started on chemotherapy with capecitabine
1500mg by mouth twice daily and oxaliplatin 130mg/m2.
The interventional radiology team evaluated the patient
for possible IVC stent placement at a later time with the
goal of alleviating venous obstruction. IVC stent place-
ment was deferred while the patient was an inpatient
because this procedure was typically reserved as palliative
treatment for patients in whom chemotherapy has limited
utility or for patients who have a poor response to
chemotherapy.
She was followed in the outpatient oncology clinic and
was scheduled for a total of six cycles of capecitabine
with oxaliplatin. Her course was complicated by gastro-
intestinal bleeding from the gastric tumor after the
fourth cycle of chemotherapy (Fig. 4). Esophagogastro-
duodenoscopy revealed a tumor that was unamenable to
endoscopic therapy. She then recovered from gastro-
intestinal bleeding. Her HER2 test result was positive
before the continuation of additional cycles of capecita-
bine and oxaliplatin, and she was thus started on trastu-
zumab 8mg/kg and paclitaxel 175mg/m2. She reported
improvement in her appetite and energy level at her fol-
low-up visits, though she continued to have abdominal
bloating. At the time this writing, she was in cycle 5 of
paclitaxel and trastuzumab.
Discussion
The initial presentation of gastric adenocarcinoma typic-
ally involves abdominal symptoms and hematologic ab-
normalities, including anemia due to gastrointestinal
blood loss. Paraneoplastic signs are sometimes the initial
manifestations. One case report of a man with a new
Patel Journal of Medical Case Reports  (2015) 9:204 Page 2 of 5
diagnosis of gastric adenocarcinoma revealed that the
first sign was multiple seborrheic keratoses on the shoul-
ders [2]. It is worthwhile to note and appreciate the less
common presentations of internal malignancy, as these
may comprise the first and only indication of early disease.
Early diagnosis, especially in cases of malignancy, can
divert poor clinical outcomes. Vena cava compression as a
result of malignancy can be a challenge to diagnose and
manage. The SVC syndrome is a well-documented feature
of lung cancer, but there exist few case reports of patients
presenting with symptoms related to mass effect on the
IVC. IVC compression is interestingly not limited to ma-
lignancies; other causes include thrombus and intrinsic
caval disease, which must be considered when performing
a workup for cancer [9].
Fig. 2 Adenocarcinoma involving the antrum of the stomach. Computed tomographic scan of the abdomen and pelvis with intravenous contrast




Fig. 1 Compression of the inferior vena cava by foci of hepatic metastases. Computed tomographic scan of the abdomen and pelvis with intravenous
contrast shows that the inferior vena cava (green arrows) becomes progressively more compressed by the tumor superiorly to inferiorly. a Patent inferior
vena cava at the level of the pancreas. d Near-complete compression of the inferior vena cava at a level of the superior portion of the kidneys. a-d
Superiorly to inferiorly
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The diagnosis of the IVC syndrome is based largely on
clinical features, including lower extremity edema, in the
setting of radiographic findings demonstrating vena cava
compression. Tachycardia can result from decreased pre-
load due to venous pooling in the lower extremities.
Imaging modalities in the past have included radio-
nuclide venography. Current methods include CT of the
abdomen, which can reveal intracaval thrombi, and mag-
netic resonance imaging with angiography [9, 10].
The treatment of vena cava compression syndromes
commonly involves stenting or radiation. Expandable
metallic stents have been used to treat IVC compression
caused by hepatic tumors [11]. Tumors that compress
the SVC, such as lung cancer, are generally radiosensi-
tive [12]. In contrast, treatment of the IVC syndrome
has not been clearly described, but presumably it involves
treating the underlying cause of compression. This may
include a combination of surgery, chemotherapy, and radi-
ation. Interventional approaches include placement of an
intravascular stent or surgical bypass grafting [5]. The
patient was noted to have significant improvement in
her lower extremity edema after initiation of capecita-
bine and oxaliplatin, likely resulting in reduction in the
size of the metastatic lesions.
To the best of my knowledge, this is the first reported
case of a patient presenting with lower extremity edema
and the IVC syndrome as a manifestation of underlying
stage IV gastric adenocarcinoma. There are some well-
known paraneoplastic manifestations of gastric adenocar-
cinomas, but IVC compression has not been previously
described. This case report emphasizes that workup of
underlying malignancy, especially primary cancers with
predilection for liver metastasis, should be done in patients
with signs and symptoms of IVC compression.
Conclusions
This is a significant case because prompt detection of
malignancy can lead to improved outcomes. This case
highlights the important components of secondary pre-
vention in gastrointestinal oncology—namely, prevention
of complications or exacerbation of disease once the
disease is diagnosed. In this case, an improvement in
outcomes was achieved by having a low threshold for
initiating a workup for malignancy in a patient who pre-
sented with the IVC syndrome.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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Fig. 3 Histologic specimens from gastric antral mass biopsy. The biopsy revealed invasive, moderately differentiated adenocarcinoma of intestinal
type, with formation of glands and nests. Shown are images at various magnifications: ×10 (a), ×20 (b), and ×40 (c)
Fig. 4 Endoscopic images of gastric tumor
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